| Schedule of antidilutive shares |
| |
|
December 31, |
|
| |
|
2018 |
|
|
2017 |
|
| Restricted stock units |
|
|
34,000 |
|
|
|
33,000 |
|
| Options to purchase common stock |
|
|
1,441,000 |
|
|
|
1,385,000 |
|
| Warrants to purchase common stock |
|
|
4,209,000 |
|
|
|
1,333,000 |
|
| Series C |
|
|
155,000 |
|
|
|
– |
|
| Common Stock Units (1) |
|
|
415,000 |
|
|
|
– |
|
| |
|
|
6,254,000, |
|
|
|
2,751,000 |
|
|
(1) |
Each unit consists of one share of common stock, par value $0.0001 per share, and one half of
one warrant to purchase one share of common stock. |
|
| Disaggregated Revenue by Source |
| |
|
Three Months Ended December 31,
|
|
|
Nine Months Ended December 31,
|
|
| |
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
| Product |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Human Skin Care |
|
$ |
4,497,000 |
|
|
$ |
4,358,000 |
|
|
$ |
12,125,000 |
|
|
$ |
11,297,000 |
|
| Animal Skin Care |
|
|
548,000 |
|
|
|
289,000 |
|
|
|
1,650,000 |
|
|
|
1,097,000 |
|
| |
|
|
5,045,000 |
|
|
|
4,647,000 |
|
|
|
13,775,000 |
|
|
|
12,394,000 |
|
| Service |
|
|
235,000 |
|
|
|
196,000 |
|
|
|
813,000 |
|
|
|
609,000 |
|
| Total |
|
$ |
5,280,000 |
|
|
$ |
4,843,000 |
|
|
$ |
14,588,000 |
|
|
$ |
13,003,000 |
|
|